MyCartis

MyCartis is a private company based in Gent, Belgium, founded in 2014. It specializes in immunodiagnostics solutions with a strong emphasis on oncology and immuno-oncology. The company has developed the Evalution platform, a biomarker analysis system that integrates various technologies to automate complex assay workflows. This platform is designed for high-throughput and precise biomarker analysis, catering to both research and clinical applications. In addition to the Evalution platform, MyCartis offers custom process automation services. They work with partners to convert technical assay workflows into automated processes, facilitating the transition from clinical research to commercial-scale manufacturing. MyCartis focuses on flexibility and innovation in instrument design, aiming to optimize cost and ease of implementation during product development. MyCartis primarily serves the life sciences research community and pharmaceutical companies involved in oncology and immuno-oncology research, supporting their efforts in personalized medicine and drug discovery.

• Employees 3
• Founded 2014
• Annual Revenue $1000000